← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Eicosis, Llc
Davis, CA
$13,392,116
Total funding
8
Grants
Funding over time
peak $3.3M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,392,116 · 8
By mechanism
UG3$6,082,654 · 1
UH3$4,749,045 · 2
R44$1,514,480 · 1
R43$771,775 · 3
UH2$274,162 · 1
Investigators at Eicosis, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics$3,046,519
UG3 · FY2020 · DA
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics$3,036,135
UG3 · FY2019 · DA
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics$2,481,856
UH3 · FY2025 · DA
Development of a Soluble Epoxide Hydrolase Inhibitor to Spare or Replace Opioid Analgesics$2,141,943
UH3 · FY2024 · DA
sEH Inhibitors to Treat Neuropathic Pain$731,876
R44 · FY2016 · ES
sEH Inhibitors to Treat Neuropathic Pain$705,128
R44 · FY2017 · ES
Identification of mechanism-based therapies to treat arrhythmogenic cardiomyopathy by resolving perturbations in regulatory lipid signaling$279,136
R43 · FY2022 · HL
Inhibiting soluble epoxide hydrolase as a treatment for chemotherapy inducedperipheral neuropathic pain$268,196
R43 · FY2019 · CA
sEH Inhibitors to Treat Neuropathic Pain$224,443
R43 · FY2014 · ES
Development of an Oral Analgesic for Neuropathic Pain$224,163
UH2 · FY2016 · NS
Development of an Oral Analgesic for Neuropathic Pain$125,246
UH3 · FY2017 · NS
sEH Inhibitors to Treat Neuropathic Pain$76,094
R44 · FY2016 · ES
Development of an Oral Analgesic for Neuropathic Pain$49,999
UH2 · FY2016 · NS
sEH Inhibitors to Treat Neuropathic Pain$1,382
R44 · FY2017 · ES